A new study announced Wednesday shows that psilocybin -- the active compound in "magic mushrooms" -- and mindfulness training ...

A single dose of psilocybin significantly decreased depression and anxiety in people with cancer, according to a new study. Psilocybin is a chemical in certain mushrooms that causes hallucinogenic ...

A single dose of psilocybin combined with psychological support can provide lasting relief from depression and anxiety in patients with cancer. In a phase 2 clinical trial, more than half of patients ...

A clinical trial examined the effects of psilocybin combined with psychological support on cancer patients diagnosed with major depressive disorder. Results showed that a single dose of psilocybin had ...

About half of patients had sustained reduction in depression and anxiety up to two years after psilocybin and psychotherapy. (HealthDay News) — For cancer patients with a major depressive disorder, a ...

(CNN) -- A single dose of psilocybin, a compound found in "magic mushrooms," provides long-term relief of anxiety and depression in cancer patients, a new study finds. In fact, cancer patients who ...

Much of the evidence documenting the earliest use of psilocybin in mushrooms for medicinal purposes by the ancient Mayans and Aztecs was destroyed by Spanish missionaries in the 1500s. However, that ...

In 1984, my grandfather took his last breath and shuffled off this mortal coil after a nasty bout with cancer. I was only 13 at the time, and probably didn’t fully understand the pain he was in. Not ...

Learn more about participating in clinical trials being conducted by NYU Langone’s Center for Psychedelic Medicine.

In January 2026, journalist and breast cancer survivor Erica Rex will release a memoir that refuses to celebrate the ...

Frontline healthcare workers struggling with depression after the COVID-19 pandemic experienced significant relief from a treatment combining psilocybin group therapy with mindfulness training, ...

UCLA study finds magic mushrooms can help curb the anxiety of advanced cancer. Sept. 7, 2010— -- When 55-year-old California software developer Pam Sakuda was diagnosed with metastic colon cancer ...